Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
Murad Atmaca Department of Psychiatry, Firat University School of Medicine, Elazig, TurkeyCorrespondence: Murad AtmacaFirat (Euphrates) Universitesi, Firat Tip Merkezi, Psikiyatri Anabilim Dali, Elazig 23119, TurkeyTel +90 424 233 3555Fax +90 424 238 7688Email matmaca_p@yahoo.comAbstract: Any type o...
Enregistré dans:
Auteur principal: | Atmaca M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e934a7a3842b4e35962f9b9782c049a0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
par: Novick D, et autres
Publié: (2016) -
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
par: Najmeh Shahini, et autres
Publié: (2021) -
Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
par: Xin KZ, et autres
Publié: (2019) -
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
par: Mike Briley, et autres
Publié: (2010) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
par: Zhong Z, et autres
Publié: (2017)